|
|
||||||||
Published online before print July 24, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

* Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases, and
Institute of Immunology, Vienna Competence Center, Medical University of Vienna, Vienna, Austria
1 Correspondence: Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases, Vienna Competence Center, Medical University of Vienna, Lazarettgasse 19, Vienna 1090 , Austria. E-mail: adelheid.elbe-buerger{at}meduniwien.ac.at
As the phenotype of adult dermal stem cells is still elusive, and the hematopoietic stem cell is one of the best-characterized stem cells in the body, we tested dermal cell suspensions, sections, and wholemounts in newborn and adult mice for hematopoietic stem cell marker expression. Phenotypic analysis revealed that a small population of CD45+ cells and a large population of CD45 cells expressed CD34, CD117, and stem cell antigen-1 molecules. When cultivated in selected media supplemented with hematopoietic cytokines, total dermal cells, lineage, and/or highly enriched phenotypically defined cell subsets produced hematopoietic and nonhematopoietic colonies. When injected into lethally irradiated recipient mice, a small percentage of newborn dermal cells was able to migrate into hematopoietic tissues and the skin and survived through the 11-month monitoring period. Our ability to isolate a candidate autologous stem cell pool will make these cells ideal vehicles for genetic manipulation and gene therapy.
Key Words: dermis mouse single cell suspension semisolid medium hematopoietic cytokines
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |